Laurus has completed the expansion for Lamivudine with its offtake expected to increase over the near term.
Implementation of the Real Estate (Regulation and Development) Act (RERA), 2016, also brought about a paradigm shift in the construction…
The strength of the ‘Godrej’ brand and its association with trust, quality and reliability helps the company across segments, particularly…
We value JSWE on an SOTP basis; the long-term PPA capacities on DCF and merchant capacities at `0.4 crore/MW. The…
The company is in process of converting its INR loans to USD, as it can provide a natural hedge against…
ALKEM has ramped up its US sales to 6x over FY13-18 on new launches, reasonable market share gains in existing…
At 17x FY20e, and with L&T market purchase/open offer at Rs 980/share, upside seems capped; ‘Buy’ under review after recent…
A small short-term blip was seen in the Q4FY19 demand. But, we had already built in an 8% volume growth…
Standalone EPS CAGR of 16% likely over FY18-21e; multiple triggers exist for medium-term growth; TP revised to Rs 389 from…
Delta Corp has made another strategic investment with the acquisition of 15.52% stake in Halaplay (a fantasy sports platform) for…
The North America — a key market for UPLL – is the third largest agrochemical market after LatAm and Europe.
SIPL has already entered into an exclusivity contract with potential buyer
Rs 320-bn raise would allow Bharti to be self-sufficient without a rise in ARPU; cash burn is likely to come…
This was a result of weak tax receipts and higher spending; indirect taxes hit revenue collection the most.
However, post the INR250b fund raise, FY19 net debt/EBITDA would come down sharply to 3.5x with net debt of INR898b.
Growth in Chronic segment (contributed around half of sales) exceeded that in Acute segment.
Traditionally, revenue growth has been a key lever for margin expansion in the industry.
Company’s a unique play on retail growth story; its operational portfolio will double in four years; ‘Buy’ retained with TP…
